|
|
|
Vol. 12, No. 13, pp. 1975-1985, July 1, 1998
Center for Advanced Biotechnology and Medicine, Cancer Institute
of New Jersey, Department of Molecular Biology and Biochemistry,
Rutgers University, Piscataway, New Jersey 08854 USA
The p53 tumor suppressor gene product interacts with the p300
transcriptional coactivator that regulates the transactivation of
p53-inducible genes. The adenovirus E1A protein has been shown to bind
to p300 and inhibit its function. E1A inhibits p53 transactivation and
also promotes p53 accumulation by a p300-dependent mechanism. Murine
double minute 2 (Mdm2) is a transcriptional target of p53 that binds to
p53 and inhibits its transcriptional activity. E1A inhibited
mdm2 transactivation without affecting the expression of
p21WAF1 or Bax, which resulted in high levels
of p53 accumulation and apoptosis. Ectopic expression of p300 restored
Mdm2 levels and inhibited p53-dependent apoptosis, as did ectopic
expression of Mdm2. Thus, p300 is required for mdm2 induction
by p53 and the subsequent inhibition of p53 stabilization. Inhibition
of p300 by E1A results in stabilization of p53 and causes apoptosis.
Moreover, E1B 19K or Bcl-2 expression in E1A-transformed cells
abrogated p53-dependent apoptosis by restoring mdm2
transactivation by p53. Hence, p300 regulation of mdm2
expression controls apoptotic activity of p53, and 19K or Bcl-2 bypass
E1A inhibition of p300 transactivation of Mdm2.
[Key Words: p53; Mdm2; p300; apoptosis; Bcl-2; E1B 19K; E1A; transcription]
This article has been cited by other articles:
![]() |
A. V. Samuelson, M. Narita, H.-M. Chan, J. Jin, E. de Stanchina, M. E. McCurrach, M. Narita, M. Fuchs, D. M. Livingston, and S. W. Lowe p400 Is Required for E1A to Promote Apoptosis J. Biol. Chem., June 10, 2005; 280(23): 21915 - 21923. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Iyer, S.-F. Chin, H. Ozdag, Y. Daigo, D.-E. Hu, M. Cariati, K. Brindle, S. Aparicio, and C. Caldas p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels PNAS, May 11, 2004; 101(19): 7386 - 7391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, N.-J. Kwak, J. Y. Lee, B. H. Choi, Y. Lim, Y. J. Ko, Y.-H. Kim, P.-W. Huh, K.-H. Lee, H. K. Rha, et al. Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53 J. Biol. Chem., February 27, 2004; 279(9): 7812 - 7818. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mancini, F. Gentiletti, M. D'Angelo, S. Giglio, S. Nanni, C. D'Angelo, A. Farsetti, G. Citro, A. Sacchi, A. Pontecorvi, et al. MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis J. Biol. Chem., February 27, 2004; 279(9): 8169 - 8180. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ganguli and B. Wasylyk p53-Independent Functions of MDM2 Mol. Cancer Res., December 1, 2003; 1(14): 1027 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Almog, M. Milyavsky, P. Stambolsky, A. Falcovitz, N. Goldfinger, and V. Rotter The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop Carcinogenesis, May 1, 2001; 22(5): 779 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Querido, M. R. Morisson, H. Chu-Pham-Dang, S. W.-L. Thirlwell, D. Boivin, and P. E. Branton Identification of Three Functions of the Adenovirus E4orf6 Protein That Mediate p53 Degradation by the E4orf6-E1B55K Complex J. Virol., January 15, 2001; 75(2): 699 - 709. [Abstract] [Full Text] |
||||
![]() |
H. M. Chan and N. B. La Thangue p300/CBP proteins: HATs for transcriptional bridges and scaffolds J. Cell Sci., January 7, 2001; 114(13): 2363 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, X. Jin, C. Page, V. K. Sondak, G. Jiang, and R. K. Reynolds A Modified p53 Overcomes mdm2-mediated Oncogenic Transformation: A Potential Cancer Therapeutic Agent Cancer Res., October 1, 2000; 60(20): 5895 - 5901. [Abstract] [Full Text] |
||||
![]() |
M. V. BLAGOSKLONNY p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect FASEB J, October 1, 2000; 14(13): 1901 - 1907. [Abstract] [Full Text] |
||||
![]() |
C. Wasylyk and B. Wasylyk Defect in the p53-Mdm2 Autoregulatory Loop Resulting from Inactivation of TAFII250 in Cell Cycle Mutant tsBN462 Cells Mol. Cell. Biol., August 1, 2000; 20(15): 5554 - 5570. [Abstract] [Full Text] |
||||
![]() |
C. Albanese, M. D'Amico, A. T. Reutens, M. Fu, G. Watanabe, R. J. Lee, R. N. Kitsis, B. Henglein, M. Avantaggiati, K. Somasundaram, et al. Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis J. Biol. Chem., November 26, 1999; 274(48): 34186 - 34195. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Medina, W. Sheay, L. Goodell, P. Kidd, E. White, A. B. Rabson, and R. K. Strair Adenovirus-Mediated Cytotoxicity of Chronic Lymphocytic Leukemia Cells Blood, November 15, 1999; 94(10): 3499 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Lu, Y.-R. Lou, P. Yen, D. Mitchell, M.-T. Huang, and A. H. Conney Time Course for Early Adaptive Responses to Ultraviolet B Light in the Epidermis of SKH-1 Mice Cancer Res., September 1, 1999; 59(18): 4591 - 4602. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sabbatini and F. McCormick Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent Apoptosis J. Biol. Chem., August 20, 1999; 274(34): 24263 - 24269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knauf, R. Elisei, D. Mochly-Rosen, T. Liron, X.-N. Chen, R. Gonsky, J. R. Korenberg, and J. A. Fagin Involvement of Protein Kinase Cepsilon (PKCepsilon ) in Thyroid Cell Death. A TRUNCATED CHIMERIC PKCepsilon CLONED FROM A THYROID CANCER CELL LINE PROTECTS THYROID CELLS FROM APOPTOSIS J. Biol. Chem., August 13, 1999; 274(33): 23414 - 23425. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kohn Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734. [Abstract] [Full Text] |
||||
![]() |
G. M. Kasof, L. Goyal, and E. White Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins Mol. Cell. Biol., June 1, 1999; 19(6): 4390 - 4404. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Sionov, E. Moallem, M. Berger, A. Kazaz, O. Gerlitz, Y. Ben-Neriah, M. Oren, and Y. Haupt c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53 J. Biol. Chem., March 26, 1999; 274(13): 8371 - 8374. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Lambert, F. Kashanchi, M. F. Radonovich, R. Shiekhattar, and J. N. Brady Phosphorylation of p53 Serine 15 Increases Interaction with CBP J. Biol. Chem., December 4, 1998; 273(49): 33048 - 33053. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sherr Tumor surveillance via the ARF-p53 pathway Genes & Dev., October 1, 1998; 12(19): 2984 - 2991. [Full Text] |
||||